| [1] |
Kraft P, Schuhmann MK, Fluri F, et al. Efficacy and safety of platelet glycoprotein receptor blockade in aged and comorbid mice with acute experimental stroke[J]. Stroke, 2015, 46 (12): 3502-3506.
|
| [2] |
Bone RC, Francis PB, Pierce AK. Intravascular coagulation associated with the adult respiratory distress syndrome[J]. Am J Med, 1976, 61 (5): 585-589.
|
| [3] |
Middleton EA, Weyrich AS, Zimmerman GA. Platelets in pulmonary immune responses and inflammatory lung diseases[J]. Physiol Rev, 2016, 96 (4): 1211-1259.
|
| [4] |
Kayo S, Ikura Y, Suekane T, et al. Close association between activated platelets and neutrophils in the active phase of ulcerative colitis in humans[J]. Inflamm Bowel Dis, 2006, 12 (8): 727-735.
|
| [5] |
Rooks MG, Garrett WS. Gut microbiota, metabolites and host immunity[J]. Nat Rev Immunol, 2016, 16 (6): 341-352.
|
| [6] |
Mowat AM. Anatomical basis of tolerance and immunity to intestinal antigens[J]. Nat Rev Immunol, 2003, 3 (4): 331-341.
|
| [7] |
Nagler-Anderson C. Man the barrier! Strategic defences in the intestinal mucosa[J]. Nat Rev Immunol, 2001, 1 (1): 59-67.
|
| [8] |
Spadoni I, Fornasa G, Rescigno M. Organ-specific protection mediated by cooperation between vascular and epithelial barriers[J]. Nat Rev Immunol, 2017, 17 (12): 761-773.
|
| [9] |
Bischoff SC, Barbara G, Buurman W, et al. Intestinal permeability--a new target for disease prevention and therapy[J]. BMC Gastroenterol, 2014 (14): 1-25.
|
| [10] |
Daneman R, Rescigno M. The gut immune barrier and the blood-brain barrier: are they so different?[J] Immunity, 2009, 31 (5): 722-735.
|
| [11] |
Spadoni I, Zagato E, Bertocchi A, et al. A gut-vascular barrier controls the systemic dissemination of bacteria[J]. Science, 2015, 350 (6262): 830-834.
|
| [12] |
Hanna N, Bialowas C, Fernandez C. Septicemia secondary to ileus in trauma patients: a human model for bacterial translocation[J]. South Med J, 2010, 103 (5): 461-463.
|
| [13] |
吴玉霞，袁忠，马西虎，等.从脾论治慢性原发性免疫性血小板减少性症临床疗效观察[J].世界中医药，2016，11（9）：1782-1785.
|
| [14] |
Leslie M. Beyond clotting: the powers of platelets[J]. Science, 2010, 328 (5978): 562-564.
|
| [15] |
Polanowska-Grabowska R, Wallace K, Field JJ, et al. P-selectin-mediated platelet-neutrophil aggregate formation activates neutrophils in mouse and human sickle cell disease[J]. Arterioscler Thromb Vasc Biol, 2010, 30 (12): 2392-2399.
|
| [16] |
Drachenberg CB, Papadimitriou JC. Endothelial injury in renal antibody-mediated allograft rejection: a schematic view based on pathogenesis[J]. Transplantation, 2013, 95 (9): 1073-1083.
|
| [17] |
Thurston G, Rudge JS, Ioffe E, et al. Angiopoietin-1 protects the adult vasculature against plasma leakage[J]. Nat Med, 2000, 6 (4): 460-463.
|
| [18] |
Rodrigues SF, Granger DN. Role of blood cells in ischaemia-reperfusion induced endothelial barrier failure[J]. Cardiova Res, 2010, 87 (2): 291-299.
|
| [19] |
Knezevic II, Predescu SA, Neamu RF, et al. Tiam1 and Rac1 are required for platelet-activating factor-induced endothelial junctional disassembly and increase in vascular permeability[J]. J Biol Chem, 2009, 284 (8): 5381-5394.
|
| [20] |
Coeffier E, Delautier D, Le Couedic JP, et al. Cooperation between platelets and neutrophils for paf-acether (platelet-activating factor) formation[J]. J Leukoc Biol, 1990, 47 (3): 234-243.
|
| [21] |
Dhanesha N, Prakash P, Doddapattar P, et al. Endothelial cell-derived von willebrand factor is the major determinant that mediates von willebrand factor-dependent acute ischemic stroke by promoting postischemic thrombo-inflammation[J]. Arterioscler Thromb Vasc Biol, 2016, 36 (9): 1829-1837.
|
| [22] |
Chen C, Li T, Zhao Y, et al. Platelet glycoprotein receptor Ⅰb blockade ameliorates experimental cerebral ischemia-reperfusion injury by strengthening the blood-brain barrier function and anti-thrombo-inflammatory property[J]. Brain Beha Immun, 2018 (69): 255-263.
|
| [23] |
Gevers D, Kugathasan S, Denson LA, et al. The treatment-naive microbiome in new-onset Crohn's disease[J]. Cell Host Microbe, 2014, 15 (3): 382-392.
|
| [24] |
Duboc H, Rajca S, Rainteau D, et al. Connecting dysbiosis, bile-acid dysmetabolism and gut inflammation in inflammatory bowel diseases[J]. Gut, 2013, 62 (4): 531-539.
|
| [25] |
Chiodini RJ, Dowd SE, Galandiuk S, et al. The predominant site of bacterial translocation across the intestinal mucosal barrier occurs at the advancing disease margin in Crohn's disease[J]. Microbiology, 2016, 162 (9): 1608-1619.
|
| [26] |
Ott C, Scholmerich J. Extraintestinal manifestations and complications in IBD[J]. Nat Rev Gastroenterol Hepatol, 2013, 10 (10): 585-595.
|
| [27] |
Danese S, De La Motte C, Fiocchi C. Platelets in inflammatory bowel disease: clinical, pathogenic, and therapeutic implications[J]. Am J Gastroenterol, 2004, 99 (5): 938-945.
|
| [28] |
Morowitz DA, Allen LW, Kirsner JB. Thrombocytosis in chronic inflammatory bowel disease[J]. Ann Intern Med, 1968, 68 (5): 1013-1021.
|
| [29] |
Talstad I, Rootwelt K, Gjone E. Thrombocytosis in ulcerative colitis and Crohn's disease[J]. Scand J Gastroenterol, 1973, 8 (2): 135-138.
|
| [30] |
Chiarantini E, Valanzano R, Liotta AA, et al. Persistence of hemostatic alterations in patients affected by Crohn's disease after bowel surgery[J]. Thromb Res, 1997, 87 (6): 539-546.
|
| [31] |
Nakarai A, Kato J, Hiraoka S, et al. An elevated platelet count increases the risk of relapse in ulcerative colitis patients with mucosal healing[J]. Gut Liver, 2018, 12 (4): 420-425.
|
| [32] |
Zezos P, Kouklakis G, Saibil F. Inflammatory bowel disease and thromboembolism[J]. World J Gastroenterol, 2014, 20 (38): 13863-13878.
|
| [33] |
Webberley MJ, Hart MT, Melikian V. Thromboembolism in inflammatory bowel disease: role of platelets[J]. Gut, 1993, 34 (2): 247-251.
|
| [34] |
Collins CE, Cahill MR, Newland AC, et al. Platelets circulate in an activated state in inflammatory bowel disease[J]. Gastroenterology, 1994, 106 (4): 840-845.
|
| [35] |
Shen XZ, Tsung HC, Yang YW, et al. A preliminary analysis of antineoplastic activity of parvovirus MVMp NS-1 proteins[J]. Cell Res, 1997, 7 (2): 217-227.
|
| [36] |
Fox KA, Kirwan DE, Whittington AM, et al. Platelets regulate pulmonary inflammation and tissue destruction in tuberculosis[J]. Am J Respir Crit Care Med, 2018, 198 (2): 245-255.
|
| [37] |
Cohen AW, Carbajal JM, Schaeffer RC Jr, et al. VE-GF stimulates tyrosine phosphorylation of β-catenin and small-pore endothelial barrier dysfunction[J]. Am J Physiol, 1999, 277 (5): H2038-H2049.
|
| [38] |
Boilard E, Nigrovic PA, Larabee K, et al. Platelets amplify inflammation in arthritis via collagen-dependent microparticle production[J]. Science, 2010, 327 (5965): 580-583.
|
| [39] |
Cloutier N, Paré A, Farndale RW, et al. Platelets can enhance vascular permeability[J]. Blood, 2012, 120 (6): 1334-1344.
|
| [40] |
Boulaftali Y, Hess PR, Getz TM, et al. Platelet ITAM signaling is critical for vascular integrity in infammation[J]. J Clin Invest, 2013, 123 (2): 908-916.
|
| [41] |
Toner P, McAuley DF, Shyamsundar M. Aspirin as a potential treatment in sepsis or acute respiratory distress syndrome[J]. Crit Care, 2015 (19): 374.
|
| [42] |
Langer HF, Chavakis T. Platelets and neurovascular inflammation[J]. Thromb Haemost, 2013, 110 (5): 888-893.
|
| [43] |
宋立成，韩志海.脓毒症相关凝血功能障碍机制及治疗的研究进展[J/CD].中华危重症医学杂志（电子版），2017，10（2）：125-129.
|
| [44] |
张德厚，陈义坤，刘大东.脓毒症患者早期血小板功能变化及预后分析[J/CD].中华危重症医学杂志（电子版），2017，10（1）：28-33.
|